{
    "title": "New drugs contribute to AbbVie's upbeat 2020 view; shares hit year-high",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-7979067/New-drugs-contribute-AbbVies-upbeat-2020-view-shares-hit-year-high.html",
    "date": "2020-02-07",
    "keywords": [
        "humira",
        "abbvie",
        "quarter",
        "revenue",
        "rinvoq",
        "tamara",
        "protection",
        "share",
        "forecast",
        "deal",
        "psoriasis",
        "skyrizi",
        "arthritis",
        "treatment",
        "position",
        "market",
        "inc",
        "wall",
        "street",
        "acquisition",
        "plc",
        "growth",
        "cash",
        "cow",
        "patent",
        "level",
        "year",
        "profit",
        "impact",
        "company",
        "drug",
        "prescription",
        "medicine",
        "companys",
        "dependence",
        "leadership",
        "immunology",
        "autoimmune",
        "coverage",
        "disease",
        "atopic",
        "dermatitis",
        "president",
        "michael",
        "severino",
        "conference",
        "call",
        "addition",
        "wrinkle",
        "botox",
        "development",
        "drop",
        "competition",
        "light",
        "stage",
        "pipeline",
        "performance",
        "stock",
        "analyst",
        "baum",
        "delivery",
        "line",
        "estimate",
        "reporting",
        "bengaluru",
        "carl",
        "york",
        "editing",
        "koyyur",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}